Ever Source Wealth Advisors, LLC Karuna Therapeutics, Inc. Transaction History

Ever Source Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$161.01 - $317.85 $4,991 - $9,853	31 Added 54.39%	88 $27,000
Q3 2023 Nov 03, 2023	BUY	$164.66 - $218.08 $3,457 - $4,579	21 Added 58.33%	57 $9,000
Q2 2023 Aug 04, 2023	BUY	$176.32 - $240.22 $1,763 - $2,402	10 Added 38.46%	36 $7,000
Q1 2023 May 11, 2023	BUY	$161.33 - $204.36 $1,613 - $2,043	10 Added 62.5%	26 $4,000
Q3 2022 Nov 07, 2022	BUY	$123.79 - $277.42 $1,980 - $4,438	16 New	16 $4,000
Q2 2022 Aug 01, 2022	SELL	$93.97 - $143.33 $4,698 - $7,166	-50 Closed	0 $0
Q1 2022 May 25, 2022	SELL	$98.9 - $132.37 $1,483 - $1,985	-15 Reduced 23.08%	50 $6,000
Q4 2021 Feb 07, 2022	BUY	$110.64 - $159.4 $7,191 - $10,361	65 New	65 $9,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.